source
- Tandem Diabetes Care gets FDA clearance for tubeless insulin delivery system with up to 7-day wearTandem Diabetes Care announced that the FDA has cleared its Tandem Mobi system as a tubeless automated insulin delivery device. The clearance allows the device to be worn for up to seven days witho…
- China adds CAR-T therapy to national insurance list, slashing price to $40,000China has added a CAR-T therapy to its National Reimbursement Drug List, cutting the price to $40,000. The reduction brings the treatment within the scope of basic medical insurance, improving aff…